Scientific Reports · 2023 · 25 citations · 30 references
Life SciencesMolecular BiologyOncologyMolecular OncologyProteomicsTumor ImmunologyCancer ProteomicsClinical ProteomicsMolecular Tumor ProfilingProteomic BiomarkersImmunoproteasome FunctionMolecular Prognostic MarkersPrognostic Tumor MarkersProteasome Inhibitor TherapyProteasome InhibitorsProteasome SystemProtein Expression BiomarkersTumor Proteomics
Proteasome dependency is a feature of many cancers that can be targeted by proteasome inhibitors. For some cancer types, notably breast cancer and triple-negative breast cancer (TNBC), high mRNA expression of a modified form of the proteasome, called the immunoproteasome (ImP), correlates with better outcomes and higher expression of one ImP subunit was associated with slower tumor growth in a small patient cohort. While these findings are in line with an anti-tumoral role of the ImP in breast cancer, studies investigating ImP expression at the protein level in large patient cohorts are lacking. Furthermore, while ImPs can be found in both immune and non-immune cells, the cellular source is often ignored in correlative studies. In order to determine the impact of ImP expression on breast cancer outcomes, we assessed the protein expression and cellular source of the ImP subunits PSMB8 and PSMB9 in a cohort of 2070 patients. Our data show a clear correlation between high ImP expression and better outcomes, most notably for TNBC patients and when tumor cells rather than stromal or immune cells express PSMB8 or PSMB9. Our results therefore suggest that ImP expression by tumor cells could be used as prognostic markers of TNBC outcomes.
30
Rebecca L. Siegel, Kimberly D. Miller, Hannah E. Fuchs et al. · CA A Cancer Journal for Clinicians · 2022 · 18.2K citations · Full text
How basal are triple‐negative breast cancers?
François Bertucci, Pascal Finetti, Nathalie Cervera et al. · International Journal of Cancer · 2008 · 437 citations · Full text
Medicine, Cancer Biology, Oncology +16
Approval Summary for Bortezomib for Injection in the Treatment of Multiple Myeloma
Peter Bross, Robert C. Kane, Ann T. Farrell et al. · Clinical Cancer Research · 2004 · 340 citations · Full text